AU782403B2 - Method for reducing or eliminating smoking - Google Patents

Method for reducing or eliminating smoking Download PDF

Info

Publication number
AU782403B2
AU782403B2 AU38289/01A AU3828901A AU782403B2 AU 782403 B2 AU782403 B2 AU 782403B2 AU 38289/01 A AU38289/01 A AU 38289/01A AU 3828901 A AU3828901 A AU 3828901A AU 782403 B2 AU782403 B2 AU 782403B2
Authority
AU
Australia
Prior art keywords
nicotine
alternative
tobacco
individual
source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU38289/01A
Other languages
English (en)
Other versions
AU3828901A (en
Inventor
Theodore K. Kyle
Saul Shiffman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haleon UK IP Ltd
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU3828901A publication Critical patent/AU3828901A/en
Application granted granted Critical
Publication of AU782403B2 publication Critical patent/AU782403B2/en
Assigned to GLAXOSMITHKLINE LLC reassignment GLAXOSMITHKLINE LLC Request to Amend Deed and Register Assignors: SMITHKLINE BEECHAM CORPORATION
Assigned to GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) IP LIMITED reassignment GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) IP LIMITED Request for Assignment Assignors: GLAXOSMITHKLINE LLC
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicinal Preparation (AREA)
AU38289/01A 2000-02-15 2001-02-15 Method for reducing or eliminating smoking Expired AU782403B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/504,560 US6660754B1 (en) 2000-02-15 2000-02-15 Method for reducing or eliminating smoking
US09/504560 2000-02-15
PCT/US2001/004798 WO2001060364A1 (en) 2000-02-15 2001-02-15 Method for reducing or eliminating smoking

Publications (2)

Publication Number Publication Date
AU3828901A AU3828901A (en) 2001-08-27
AU782403B2 true AU782403B2 (en) 2005-07-28

Family

ID=24006789

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38289/01A Expired AU782403B2 (en) 2000-02-15 2001-02-15 Method for reducing or eliminating smoking

Country Status (20)

Country Link
US (2) US6660754B1 (https=)
EP (1) EP1265610A4 (https=)
JP (1) JP2003522789A (https=)
KR (1) KR20020075795A (https=)
CN (1) CN1400901A (https=)
AR (1) AR032440A1 (https=)
AU (1) AU782403B2 (https=)
BR (1) BR0108318A (https=)
CA (1) CA2400353A1 (https=)
CO (1) CO5261581A1 (https=)
CZ (1) CZ20022766A3 (https=)
EA (1) EA004184B1 (https=)
EG (1) EG22199A (https=)
HU (1) HUP0301131A3 (https=)
MY (1) MY127259A (https=)
NZ (1) NZ520586A (https=)
PE (1) PE20011221A1 (https=)
PL (1) PL357013A1 (https=)
WO (1) WO2001060364A1 (https=)
ZA (1) ZA200207217B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050112148A1 (en) * 2003-11-21 2005-05-26 Dmitruk Victor M. Habit based self-help method for smoking cessation
US20070134169A1 (en) * 2005-12-11 2007-06-14 Rabinoff Michael D Methods for smoking cessation or alcohol cessation or other addiction cessation
US20080230078A1 (en) * 2007-03-19 2008-09-25 Oby George Tolman Method of smoking cessation
EP2515918B1 (en) * 2009-12-21 2014-10-08 RCP Development, Inc. Smoking cessation lozenge containing tobacco alkaloid and silver salt
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
CN101858902B (zh) * 2010-06-01 2012-12-12 中国科学院广州地球化学研究所 一种结合碳同位素比值的土壤蚀变碳酸盐的测量方法
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
CN108685184B (zh) * 2017-04-11 2020-06-16 常州市派腾电子技术服务有限公司 辅助戒烟方法及辅助戒烟装置
CN107149028A (zh) * 2017-04-17 2017-09-12 廖华勇 内含微量烟草气味的香口胶

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055478A (en) * 1986-06-19 1991-10-08 Cooper Thomas M Method for stopping smoking

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5488962A (en) 1990-10-10 1996-02-06 Perfetti, S.P.A. Chewing gum which is a substitute for tobacco smoke
AR030092A1 (es) * 2000-08-02 2003-08-13 Smithkline Beecham Corp Metodo para reducir o eliminar el fumar

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055478A (en) * 1986-06-19 1991-10-08 Cooper Thomas M Method for stopping smoking

Also Published As

Publication number Publication date
EA004184B1 (ru) 2004-02-26
AU3828901A (en) 2001-08-27
BR0108318A (pt) 2003-02-18
US20040058966A1 (en) 2004-03-25
MY127259A (en) 2006-11-30
KR20020075795A (ko) 2002-10-05
ZA200207217B (en) 2003-08-04
US6660754B1 (en) 2003-12-09
CA2400353A1 (en) 2001-08-23
CO5261581A1 (es) 2003-03-31
NZ520586A (en) 2004-11-26
PL357013A1 (en) 2004-07-12
CZ20022766A3 (cs) 2003-05-14
HUP0301131A3 (en) 2004-01-28
JP2003522789A (ja) 2003-07-29
HUP0301131A2 (hu) 2003-08-28
EA200200765A1 (ru) 2003-02-27
AR032440A1 (es) 2003-11-12
CN1400901A (zh) 2003-03-05
EP1265610A1 (en) 2002-12-18
WO2001060364A1 (en) 2001-08-23
EP1265610A4 (en) 2008-04-02
PE20011221A1 (es) 2002-02-07
EG22199A (en) 2002-10-31

Similar Documents

Publication Publication Date Title
Schneider et al. Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial
AU782403B2 (en) Method for reducing or eliminating smoking
Rose Nicotine and nonnicotine factors in cigarette addiction
Shiffman et al. Nicotine delivery systems
Glover et al. A multicenter phase 3 trial of lobeline sulfate for smoking cessation
Lillington et al. Smoking cessation: techniques and benefits
Jarvik et al. Pharmacological adjuncts for the treatment of tobacco dependence
US6224897B1 (en) Methods to abate the use of tobacco by humans
Prignot Pharmacological approach to smoking cessation
Corelli et al. Medications for smoking cessation
US5414005A (en) Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
AU2001284704B2 (en) Method for reducing or eliminating smoking
Tønnesen Smoking cessation programs
US20040024028A1 (en) Method for reducing or eliminating smoking
AU2001284704A1 (en) Method for reducing or eliminating smoking
Bhattacharyya et al. Therapy for Cessation of Smoking
Ostrowski et al. Pharmacologic management of patients using smoking cessation aids
Ellingrod Smoking cessation: What to tell patients about over-the-counter treatments
Asadi et al. A Narrative Review on Smoking Cessation Pharmacotherapy. To-bacco and Health 2023; 2 (4): 155-162
Lauro et al. Update on the treatment of smoking dependence
Coulehan The doctor's wife
Joshi Nicotine Replacement Therapy-A Review
Shiffman et al. Nicotine Delivery Systems
Srivastava et al. Journal of Dental Herald
Corelli Medicine Cabinet

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) IP LIMITED

Free format text: FORMER OWNER(S): GLAXOSMITHKLINE LLC

MK14 Patent ceased section 143(a) (annual fees not paid) or expired